Digital health technologies have the potential to benefit the FTD community by improving accessibility to research and clinical care. Such technologies were the focus of the 2022 Holloway Summit — a summary of which was recently published in the journal Alzheimer’s & Dementia.

The article highlights several digital health technologies being developed to remotely assess FTD onset and progression. Additionally, the article provides a framework for tool developers outlining key considerations for efficient, effective digital health technology development for FTD.

Meeting co-chairs Jonathan Rohrer, MD, PhD, and Naomi Nevler, MD, led the production of the article’s manuscript, alongside several of the 2022 Holloway Summit speakers. Both the annual Holloway Summit meetings and this manuscript have been made possible through the generosity of Kristin Holloway and the Holloway Family Fund.